Draft guidance consultation
Open for comments Open until Request commenting lead permission
We have updated this service so that members of the same organisation can now collaborate on a joint online response.
Read our blog to learn more.
ID6130 leniolisib APDS DG to PM for consultation - Web version 281024VM [noCON].docx
Leniolisib for activated phosphoinositide 3‑kinase delta syndrome in people 12 years and over
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions
Question on Consultation
Question on Consultation
Question on Consultation
Question on Consultation